Commencement of final phase of human studies

Commencement of final phase of human studies

Manchester, UK - 20 November 2018 - SkinBioTherapeutics plc (AIM: SBTX - "SkinBioTherapeutics" or the "Company"), a life science company focused on skin health, announces the commencement of the third and final phases of its human study and provides a summary of key scientific a...

20th November, 2018 Read More

SkinBiotix® technology generates positive data in first two elements of its human study

SkinBiotix® technology generates positive data in first two elements of its human study

Manchester, UK - 7 November 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, announces positive data from the first two elements of its human study which focus on skin irritancy and moisturisation potential....

7th November, 2018 Read More

Full Year Results

Full Year Results

Manchester, UK - 25 October 2018 - SkinBioTherapeutics plc (AIM: SBTX - "SkinBioTherapeutics" or the "Company") a life sciences company focused on skin health, has announced its full year results for the year to 30 June 2018....

25th October, 2018 Read More

CEO Presentation

CEO Presentation

CEO, Prof. Cath O'Neill presenting at the AJ Bell Investor Evening https://www.sharesmagazine.co.uk/video/dr-catherine-oneill-ceo-skinbiotherapeutics-sbtx-2...

17th October, 2018 Read More

Human study commenced

Human study commenced

Manchester, UK - 19 September 2018 - SkinBioTherapeutics plc (AIM: SBTX, the 'Company'), a life science company focused on skin health, confirms that it has commenced its human study being carried out on its SkinBiotix® technology....

19th September, 2018 Read More

CEO Presentation

CEO Presentation

CEO, Prof. Cath O'Neill presenting at the AJ Bell Investor Evening...

14th September, 2018 Read More
investors logo